Literature DB >> 16478591

Exploiting LH in ovarian stimulation.

C Alviggi1, A Mollo, R Clarizia, G De Placido.   

Abstract

During intermediate-late phases of human folliculogenesis, LH plays a key role in promoting steroidogenesis and growth of the leading follicle. Ovarian stimulation for assisted reproduction techniques usually consists of administering exogenous FSH in a low LH environment. Although an impairment in LH-dependent paracrine activities would be expected, multiple follicular growth is efficiently achieved in almost all patients. Thus, there appears to be a discrepancy between classical folliculogenesis models and data from IVF. This study examines the 'interface' between basic endocrinological and clinical evidence, in an attempt to answer two questions: is there an LH therapeutic window, and if there is, how can this be exploited in the practice of assisted reproduction? It also reviews the evidence that specific subgroups of women may benefit from LH supplementation during ovarian stimulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16478591     DOI: 10.1016/s1472-6483(10)60865-6

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  17 in total

1.  Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols.

Authors:  D Carone; C Caropreso; A Vitti; R Chiappetta
Journal:  J Endocrinol Invest       Date:  2012-10-22       Impact factor: 4.256

Review 2.  Lutropin alfa.

Authors:  Sohita Dhillon; Gillian M Keating
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Reduced FSH and LH action: implications for medically assisted reproduction.

Authors:  E Bosch; C Alviggi; M Lispi; A Conforti; A C Hanyaloglu; D Chuderland; M Simoni; N Raine-Fenning; P Crépieux; S Kol; V Rochira; T D'Hooghe; P Humaidan
Journal:  Hum Reprod       Date:  2021-05-17       Impact factor: 6.918

4.  A 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice: a large, multicentre, observational study.

Authors:  Klaus Bühler; Olaf Naether
Journal:  Gynecol Endocrinol       Date:  2010-09-17       Impact factor: 2.260

Review 5.  Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.

Authors:  Rogério de Barros F Leão; Sandro C Esteves
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

Review 6.  Approaches to improve the diagnosis and management of infertility.

Authors:  P Devroey; B C J M Fauser; K Diedrich
Journal:  Hum Reprod Update       Date:  2009-04-20       Impact factor: 15.610

7.  Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Alessandro Conforti; Sandro C Esteves; Peter Humaidan; Salvatore Longobardi; Thomas D'Hooghe; Raoul Orvieto; Alberto Vaiarelli; Danilo Cimadomo; Laura Rienzi; Filippo Maria Ubaldi; Fulvio Zullo; Carlo Alviggi
Journal:  Reprod Biol Endocrinol       Date:  2021-06-21       Impact factor: 5.211

Review 8.  Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.

Authors:  Philippe Lehert; Efstratios M Kolibianakis; Christos A Venetis; Joan Schertz; Helen Saunders; Pablo Arriagada; Samuel Copt; Basil Tarlatzis
Journal:  Reprod Biol Endocrinol       Date:  2014-02-20       Impact factor: 5.211

9.  Effect of BMI on blood value of patients on HCG day with IUI treatment.

Authors:  Li-Ting Wang; Cheng-Xiang Wang; Hong-Liang Sun; Xue Wang; Xue-Feng Li; Yan-Lin Wang; Qing-Chun Li
Journal:  BMC Womens Health       Date:  2020-05-14       Impact factor: 2.809

Review 10.  Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker-The Follicle-To-Oocyte (FOI) Index.

Authors:  Carlo Alviggi; Alessandro Conforti; Sandro C Esteves; Roberta Vallone; Roberta Venturella; Sonia Staiano; Emanuele Castaldo; Claus Yding Andersen; Giuseppe De Placido
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.